
Five More Must-Know Marketing Principles For MMM Success
I talked about Bethesda's hit video game Starfield in my previous article and how they managed to capture the reality of different planets; they kept the same dedication to reality when building your character's stamina, which doesn't deplete at a simple, constant rate.
Bethesda crafted a complex system where energy depletion varies based on multiple factors that don't just add together; they interact and compound, creating a dynamic system that feels authentic precisely because it mirrors the complexity of real physical exertion. We see this complexity of interaction in marketing effects as well.
In the first part of this series, we explored four fundamental laws of marketing that any effective MMM solution should reflect:
1. Top-of-funnel marketing drives awareness that manifests through other channels.
2. If you don't spend enough on the top of the funnel, you won't have a bottom of the funnel.
3. If you don't spend on the bottom of the funnel, your competition will profit from your top-of-funnel spend.
4. Marketing is inherently seasonal, and marketing efficiency changes depending on the season.
These principles aren't just theoretical—they represent the difference between making multimillion-dollar decisions based on accurate insights versus simplified abstractions that lead to wasted budgets and missed opportunities. Now, let's examine five additional marketing realities that are equally critical for measurement tools to capture and what you can do to ensure you're getting one that reflects marketing reality.
Law No. 5: Temporal Effects
Marketing isn't a series of isolated transactions—it's an ongoing process where today's activities influence tomorrow's results, which in turn affect next week's performance. Audience familiarity with your message evolves with repeated exposure. A proper measurement approach should recognize these time-based effects, accounting for marketing's impact across various time horizons and acknowledging how past activities continue to influence current performance.
Law No. 6: Variable Time Horizons
The time frame in which marketing delivers results varies dramatically by business type, product category and price point. A high-consideration purchase might show marketing effects spread across months, while impulse buys generate more immediate responses.
Sophisticated marketing mix models should adapt to your business's natural consideration cycle, recognizing that marketing impact timing is neither immediate nor uniform across brands and categories. This flexibility allows for accurate attribution regardless of whether your customers decide in minutes or months.
Law No. 7: Nonlinear (Potential) Saturation
The traditional diminishing returns curve—where each additional dollar of spend yields less incremental value—is an oversimplification of marketing reality. In reality, saturation curves often feature multiple inflection points. Seasonal factors, creative refreshes and competitor activity also continuously reshape these curves. Measurement tools that rely on simplified saturation assumptions will inevitably recommend suboptimal spend levels.
Law No. 8: Complex Decay Patterns
Marketing impact doesn't vanish instantly when a campaign ends, but neither does it decline at a neat, predictable rate. The decay of marketing effects varies by channel, audience, creative, season and competitive context.
Many marketing mix models apply standardized, predetermined decay rates to different channels (e.g., two weeks for paid social, one week for search). This approach sacrifices accuracy for simplicity. A sophisticated model should learn the actual decay patterns from your specific marketing activities and recognize how they vary across campaigns and over time.
Law No. 9: External Factors And Channel Bias
No marketing channel operates in isolation. External events affect all channels simultaneously, but often to different degrees. Similarly, changes in one channel frequently impact performance in others. The challenge is further complicated by inherent biases in platform-reported metrics. Each platform has incentives to demonstrate its own effectiveness, creating systematic biases in reported results.
An effective measurement approach must maintain neutrality across channels while accounting for these external factors. Without this holistic perspective, you can't distinguish between true marketing impact and coincidental correlation with external events.
Choosing Marketing Measurement That Reflects Reality
Selecting measurement tools that accurately reflect marketing reality requires asking the right questions:
• Does the measurement approach account for cross-channel effects and halo impacts?
• Can it identify how marketing influences organic and direct traffic?
• Does it adapt to your specific business context and consideration cycle?
• Can it capture complex saturation patterns with multiple inflection points?
• How does it account for external factors that affect marketing performance?
• Does it recognize the temporal dimension of marketing impact?
• Can it quantify the relationship between upper-funnel investment and future conversion potential?
• Can it capture the interplay between top of funnel and bottom of funnel?
The answers should align with the marketing realities we've discussed. When they don't, the measurement tool is likely sacrificing accuracy for simplicity or convenience. This isn't just about technical sophistication. The best measurement isn't necessarily the most complex, but rather the approach that most faithfully represents the marketing dynamics marketers already know to be true.
The Path Forward
The most valuable marketing measurement doesn't contradict experienced marketers' understanding; it confirms that understanding with data, adds precision to intuition and reveals nuances that even experienced marketers might miss. Like Starfield's commitment to physical reality, the best marketing measurement tools commit to marketing reality, creating a model that feels authentic because it is authentic.
Evaluating certain aspects of MMM solutions without a computer science degree can be challenging, but here, your experience is your measuring stick. Ask yourself: Does this reflect what I know to be true about how marketing works? If not, it's time to look for alternatives. Your marketing deserves to be measured in a way that's as sophisticated and nuanced as marketing itself.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
6 hours ago
- Forbes
‘Starfield' And A New Expansion Heading To PS5 In 2026, Says Report
While once upon a time, Xbox seemed determined to keep a new first party IP like Starfield to itself, since there have been massive changes to its platform philosophy, it has felt like a matter of time until it ended up on PS5. Well, that time may be coming. According to a new report from MP1st, their sources say that Starfield will be coming to PS5 in the spring of 2026, and at the same time, will release a second expansion for all platforms, along with Quality of Life updates. I would consider this more than just a random rumor, as MP1st has correctly reported on other Xbox stories ahead of the fact like the Oblivion Remastered and Persona 4 Remake reveals ahead of time. That would indicate Xbox sourcing that would in fact know something like this. Of course, nothing is a guarantee, and past that, existing plans can change. Starfield has been a strange game. It was touted as having the most players for a Bethesda launch ever, but that was of course in part due to it being on Game Pass. Its Metacritic score of an 83 was well below most other Bethesda games. Its user scores were worse, and it is sometimes viewed by fans as a game they wish Bethesda hadn't made instead of getting Elder Scrolls VI out five years sooner. FEATURED | Frase ByForbes™ Unscramble The Anagram To Reveal The Phrase Pinpoint By Linkedin Guess The Category Queens By Linkedin Crown Each Region Crossclimb By Linkedin Unlock A Trivia Ladder I would say it's less surprising that Starfield will be coming to PS5 than it is the fact that Starfield may be getting a second expansion. Again, it seems like Bethesda should be 100% focused on Elder Scrolls or other future projects. Even as someone who liked the game more than most, its first Shattered Space expansion was quite bad, and it was a mere blip on its playercount charts, indicating that vast majority of Starfield owners didn't bother with it. So they actually made another one? I'd be shocked. Despite all this, Starfield on PS5 is almost certain to do pretty well as a AAA Bethesda game at baseline. Microsoft's controversial multiplatform release strategy has so far panned out, like this past year creating a bizarre situation where Xbox is the number one publisher of games on PlayStation. Imagine telling people that ten years ago. Even with Xbox releasing many games on PS5, this one would be one of the most significant. Back when Microsoft was arguing about Call of Duty exclusivity in court, they specifically cited Starfield as a game that would remain exclusive as a new, original IP under the Bethesda they now owned. But here we are. Wild times. Follow me on Twitter, YouTube, and Instagram. Pick up my sci-fi novels the Herokiller series and The Earthborn Trilogy.
Yahoo
12 hours ago
- Yahoo
What Are Wall Street Analysts' Target Price for Host Hotels & Resorts Stock?
Bethesda, Maryland-based Host Hotels & Resorts, Inc. (HST) is the world's largest lodging real estate investment trust and one of the largest owners of luxury and upscale hotels. With a market cap of $11.2 billion, Host owns and operates several properties in the United States and internationally. The REIT has significantly underperformed the broader market over the past year. HST stock has plummeted 10.3% on a YTD basis and 11.7% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 7.8% gains in 2025 and 16.6% returns over the past year. More News from Barchart Morgan Stanley Says Nvidia Has 'Exceptional' Strength. Should You Buy NVDA Stock Here? With UnitedHealth Under DOJ Investigation, Should You Buy, Sell, or Hold UNH Stock Now? This High-Yield Dividend Stock Just Slashed Its Payout. Is It Time to Sell Now? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Narrowing the focus, Host has also underperformed the Real Estate Select Sector SPDR Fund's (XLRE) 1.8% gains in 2025 and a marginal 29 basis point uptick over the past 52 weeks. Host Hotels & Resorts' stock prices dropped 2.5% in yesterday's trading session following the release of its Q2 results on Jul. 30. While the company's financials came ahead of Street expectations, the overall performance remained mixed. The company observed a notable increase in revenues per available room, boosting its total revenues by 8.2% year-over-year to $1.6 billion, surpassing expectations by a notable 5%. However, Host has failed to optimize its cost structures, resulting in a 5.1% decline in operating profit to $277 million. Moreover, its adjusted funds from operations (AFFO) declined by about 1% to $400 million. This raised serious concerns about the REIT's ability to generate earnings and cash flow growth. For the full fiscal 2025, ending in December, analysts expect HST to report a 2.5% year-over-year drop in AFFO to $1.92 per share. On the positive note, the company has a solid earnings surprise history. It has matched or surpassed the Street's bottom-line estimates in each of the past four quarters. Host maintains a consensus 'Moderate Buy' rating overall. Of the 16 analysts covering the stock, opinions include eight 'Strong Buys,' one 'Moderate Buy,' and seven 'Holds.' This configuration is slightly less bullish than a month ago, when nine analysts gave 'Strong Buy' recommendations. On Jul. 31, Stifel analyst Simon Yarmak maintained a 'Buy' rating on HST, while raising the price target from $17 to $19. Host's mean price target of $17.91 represents a 13.9% upside potential. Meanwhile, the Street-high target of $21 suggests a notable 33.6% premium to current price levels. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
4 days ago
- Yahoo
Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis
Longhorn's validated PrimeStore® MTM sample collection device and Promega Maxwell® instruments will be offered together to laboratories globally Longhorn and Promega to showcase combined offering at the Association for Diagnostics & Laboratory Medicine conference, July 29-31, 2025 BETHESDA, Md. & GAITHERSBURG, Md., July 28, 2025--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced a strategic co-marketing agreement with Promega Corporation to deliver integrated molecular testing solutions designed to enhance safety, efficiency and flexibility across a wide range of diagnostic settings. This collaboration brings together Longhorn's validated PrimeStore® Molecular Transport Medium (MTM) and Promega's Maxwell® automated nucleic acid extraction platform, delivering a powerful, end-to-end workflow to support an all-in-one solution for safer and enhanced virus sample collection, transportation and analysis. Longhorn's PrimeStore® MTM is an inactivating molecular transport medium for both RNA and DNA. The device delivers nucleic acid samples in a time-efficient manner with Promega's Maxwell® instruments and reagent kits, designed for the automated extraction of viral total nucleic acid from a range of sample types. "The accuracy of molecular diagnostics, PCR and sequencing, starts with high quality nucleic acid," said Longhorn Vaccine and Diagnostics President Jeff Fischer. "Promega has proven that PrimeStore® MTM does just that with validation testing on their Maxwell® platform. Samples are safe to handle outside of containment, speeding up the testing time and therefore speeding up the accurate treatment of patients. The Maxwell® platform and nucleic acid extraction kits are now being added to our Instructions for Use." "Together, these technologies streamline the workflow from sample collection to high-quality nucleic acid purification without compromising on safety or performance," said Promega Director of Applied Markets Julie Yang. Longhorn and Promega will showcase their combined technologies at the upcoming Association for Diagnostics & Laboratory Medicine conference (ADLM 2025) in Chicago from July 29-31, 2025. Visit booth #3757 to learn more about PrimeStore® MTM and booth #3655 to learn more about the Maxwell® instruments and nucleic acid purification kits. A joint poster showcasing how these technologies work together was presented at the May 2025 Association of Public Health Laboratories annual conference in Portland, Oregon, titled "Validation of a Novel Sample Collection-to-Detection Workflow Using PrimeStore® MTM, Pathogen Total Nucleic Acid Kit, and PrimeMix® MTB." A second joint poster was presented at the June 2025 International Symposium of the World Association of Veterinary Laboratory Diagnosticians conference in Calgary, Alberta, titled "Novel Biosafe and Scalable Detection of Influenza A (H5N1, H3N2, H1N1) for Veterinary and One Health Applications." For more information about Longhorn, visit About Longhorn Vaccines and DiagnosticsLonghorn Vaccines and Diagnostics is a closely held One Health company based in Maryland that is developing broad coverage vaccines and diagnostic tools for worldwide public health concerns such as anti-microbial resistance, sepsis and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing broad coverage vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn products play a significant role to surveil, diagnose, prevent and treat the next infectious disease. Longhorn's core diagnostic product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization. About Promega CorporationPromega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. These tools and technologies have grown in their application over the last 45 years and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. View source version on Contacts Longhorn Vaccines and DiagnosticsJeffrey FischerEmail: jeff@ MediaAlexis Feinberg – ICR HealthcareEmail: Promega CorporationPenny PattersonE-mail: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data